Mepsevii for MPS VII Reimbursement Approval Available in Spain
source: pixabay.com

Mepsevii for MPS VII Reimbursement Approval Available in Spain

According to a recent news release from biopharmaceutical company Ultragenyx Pharmaceutical Inc. ("Ultragenyx"), the company's therapy Mepsevii (vestronidase alfa) was approved in Spain for reimbursement. The entire reimbursement process takes…

Continue Reading Mepsevii for MPS VII Reimbursement Approval Available in Spain
Compassion Corner: Being Human Does Not Take Much Effort; It Only Takes Fifty-six Seconds
source: pixabay.com

Compassion Corner: Being Human Does Not Take Much Effort; It Only Takes Fifty-six Seconds

  Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…

Continue Reading Compassion Corner: Being Human Does Not Take Much Effort; It Only Takes Fifty-six Seconds
New Data Available on KEVEYIS for PPP
https://unsplash.com/photos/8ztH-7lj8ag

New Data Available on KEVEYIS for PPP

In a news release from mid-July, 2021, biopharmaceutical company Strongbridge Biopharma plc ("Strongbridge") shared the publication of new post hoc analyses regarding KEVEYIS (dichlorphenamide) for patients with Primary Periodic Paralysis…

Continue Reading New Data Available on KEVEYIS for PPP